Egypt International Pharmaceuticals operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Egypt International Pharmaceuticals with three other
pharmaceutical manufacturers in Middle East:
October Pharma SAE
sales of 400.69 million Egyptian Pounds [US$24.67 million]
Dar Al Dawa Development and Investment Company PSC
(55.10 million Jordanian Dinars [US$77.71 million]
of which 75%
was Pharmaceuticals), and
Alexandria Pharmaceuticals and Chemical Industries Co
(650.00 million Egyptian Pounds [US$40.03 million]
During the year ended December of 2018, sales at
Egypt International Pharmaceuticals were 2.82 billion Egyptian Pounds (US$173.38 million).
increase of 11.4%
versus 2017, when the company's sales were 2.53 billion Egyptian Pounds.
This was the fifth consecutive year of sales increases at Egypt International Pharmaceuticals
(and since 2013, sales have increased a total of 107%).